0.0650
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
Operating Cash Flow
3,018.7860
-1,614.4080
-3,845.4410
-8,586.2590
-472.8890
Investing Cash Flow
20.4060
--
--
-1,685.3790
-216.1800
Financing Cash Flow
1,345.8450
2,656.0140
6,071.5580
11,501.5130
1,057.6170
End Cash Position
692.7380
591.6150
550.8660
1,623.1900
366.0650
Capital Expenditure
--
--
-95.3450
-1,707.0310
-201.3460
Issuance of Capital Stock
1,145.8770
2,656.0140
5,972.3880
7,487.9120
1,092.3460
Issuance of Debt
--
--
766.0920
3,856.1410
--
Repayment of Debt
--
--
-332.7260
-174.7900
-34.7290
Free Cash Flow
3,018.7860
-1,614.4080
-3,845.4410
-10,293.2900
-674.2350
1/31/2021 - 8/3/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OCTHF Oxford Cannabinoid Technologies Holdings Plc
0.0028
0.00%
FNAM Evolutionary Genomics, Inc.
0.0002
0.00%
RDTCF Rapid Dose Therapeutics Corp.
0.0080
0.00%
HAVLF HAVN Life Sciences Inc.
0.0010
0.00%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1390
0.00%
IGXT IntelGenx Technologies Corp.
0.1700
0.00%
IMRN Immuron Limited
1.8929
+11.35%
ABP Abpro Corporation
0.2580
+4.88%
COV.V Covalon Technologies Ltd.
2.3000
-4.17%
HLVX HilleVax, Inc.
1.6900
+2.42%